Skip to main content
Loading

Clinical Trials in Rare Oncology Disease Indications

25 Sep 2025
Clinical Development
  • Is the inclusion of a control arm appropriate in rare indications?
  • What role would synthetic arms appropriate for rare indications?
  • Selection of sites nationally or worldwide?
Industry Expert
Anthony Maida, Chief Clinical Officer - Translational Medicine - Oncotelic Therapeutics